SCHEMBL8776487

SCHEMBL8776487

c1cnc(N2CCN(CCCCc3cccc4c3[nH]c3ccccc34)CC2)nc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.50
DRD2 P14416 4/20 0.50
HTR2A P28223 3/20 0.50
DRD3 P35462 3/20 0.50
DRD1 P21728 1/20 0.50
DRD5 P21918 1/20 0.50
SIGMAR1 Q99720 1/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
DRD4 P21917 2/20 0.47
HTR7 P34969 1/20 0.47
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46
ABCB1 P08183 2/20 0.46
ABCC1 P33527 1/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30479087 0.82 SIGMAR1 (0.49) HTR1ASIGMAR1
SCHEMBL30479088 0.80 CCR3 (0.56) HTR1AHTTHTR7ABCB1ABCC1
SCHEMBL30479090 0.80 CCR3 (0.56) HTR1AHTTHTR7ABCB1ABCC1
SCHEMBL8776444 0.79 HTR1A (0.47) HTR1ADRD2HTR2ADRD3DRD1
SCHEMBL8417561 0.76 HTR1A (0.46) HTR1ADRD2HTR2ADRD3LMNA
SCHEMBL29291020 0.75 KIF11 (0.52) TSHR
SCHEMBL9400926 0.74 TSHR (0.74) HTR1ADRD2DRD3TSHRHTR7
SCHEMBL149498 0.73 ALDH1A1 (0.51) HTR2ASIGMAR1POLBTSHRABCB1
SCHEMBL11577428 0.73 KIF11 (0.53) TSHRHTT
SCHEMBL9400975 0.72 TSHR (0.71) DRD2DRD3TSHRHTR7ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808166-A1 MEDICAMENT INTENDED TO THE TREATMENT OF OBSESSIVE COMPULSIVE TROUBLES, SLEEP APNOEA, SEXUAL DYSFUNCTIONS, EMESA AND TRANSPORT SICKNESS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1997-11-26 EP claimed
WO-1997021439-A1 MEDICAMENT INTENDED TO THE TREATMENT OF OBSESSIVE COMPULSIVE TROUBLES, SLEEP APNOEA, SEXUAL DYSFUNCTIONS, EMESA AND TRANSPORT SICKNESS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1997-06-19 WO claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP claimed
EP-0808166-A1 MEDICAMENT INTENDED TO THE TREATMENT OF OBSESSIVE COMPULSIVE TROUBLES, SLEEP APNOEA, SEXUAL DYSFUNCTIONS, EMESA AND TRANSPORT SICKNESS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1997-11-26 EP disclosed
WO-1997021439-A1 MEDICAMENT INTENDED TO THE TREATMENT OF OBSESSIVE COMPULSIVE TROUBLES, SLEEP APNOEA, SEXUAL DYSFUNCTIONS, EMESA AND TRANSPORT SICKNESS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1997-06-19 WO disclosed